1. Home
  2. TUSK vs TTRX Comparison

TUSK vs TTRX Comparison

Compare TUSK & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mammoth Energy Services Inc.

TUSK

Mammoth Energy Services Inc.

HOLD

Current Price

$3.33

Market Cap

127.7M

Sector

Energy

ML Signal

HOLD

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$5.18

Market Cap

107.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TUSK
TTRX
Founded
2014
2015
Country
United States
United States
Employees
N/A
2
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
127.7M
107.2M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
TUSK
TTRX
Price
$3.33
$5.18
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
437.1K
57.9K
Earning Date
05-11-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
102.32
N/A
EPS
0.11
N/A
Revenue
$44,292,000.00
N/A
Revenue This Year
$383.90
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$34.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.72
$2.57
52 Week High
$3.92
$6.75

Technical Indicators

Market Signals
Indicator
TUSK
TTRX
Relative Strength Index (RSI) 55.02 55.42
Support Level $2.09 $3.92
Resistance Level $3.54 $5.55
Average True Range (ATR) 0.29 0.59
MACD 0.01 0.03
Stochastic Oscillator 37.09 41.24

Price Performance

Historical Comparison
TUSK
TTRX

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes rental services, infrastructure services, natural sand proppant services, accommodation services, and drilling services.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: